glp-1 patches research Gentle Review​ glp 1 patches research GLP-1

Administered once weekly, this powerful trio targets multiple pathways that influence fat metabolism, hunger regulation, energy levels, and systemic inflammation

Dose-finding RCT of diabetic patients (N = 1210) given either GLP1/GIP medication weekly or PC: After 68 weeks, mean weight loss was 10% ( GLP1/GIP medication ), 7% (lower dose GLP1/GIP medication ), and 3% (PC)

A peer-reviewed review in Frontiers in Endocrinology summarizing the mechanisms and clinical potential of peptide-based interventions for obesity and metabolic dysregulation provides the scientific foundation that positions Tesamorelin and similar peptides as credible tools in weight management beyond the GLP-1 paradigm

PMCID: PMC8635774

Find out 15 ways to raise your glutathione.